Pharmaceuticals

Norovirus Treatment Market Outlook Indicating Growth Toward $3.22 Billion by 2030

March 23, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Norovirus Treatment Market Over The Period 2026–2030?

The norovirus treatment market has seen rapid expansion in recent years. This market is projected to expand from $1.94 billion in 2025 to $2.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.9%. The historical growth can be linked to several factors, including limited awareness surrounding norovirus management, a reliance on hospital-based treatments, insufficient homecare infrastructure, a lack of standardized symptom management protocols, and low adoption rates of probiotics and zinc supplementation.

The norovirus treatment market size is anticipated to experience swift expansion in the coming years, with projections indicating it will reach $3.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.6%. This expected growth can be attributed to several factors including an escalating demand for oral rehydration solutions, the expansion of homecare services and telemedicine, a growing focus on the pediatric and elderly populations, the development of targeted supportive care therapies, increasing healthcare expenditure, and impactful awareness campaigns. Throughout the forecast period, significant trends are set to include a greater adoption of oral rehydration therapies, an increased utilization of intravenous fluids in severe instances, the proliferation of homecare and remote treatment alternatives, a broader application of anti-diarrheal and symptom management drugs, and a dedicated emphasis on norovirus care for both children and the elderly.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24629&type=smp

Which Economic Or Industry Drivers Are Impacting The Norovirus Treatment Market?

The anticipated rise in infectious diseases is projected to boost the expansion of the norovirus treatment market in the future. These diseases are conditions resulting from bacteria, viruses, fungi, or parasites that are transmissible among individuals, encompassing examples such as influenza, tuberculosis, HIV/AIDS, malaria, and norovirus. The growing incidence of infectious disease is attributed to urban overcrowding, a factor that promotes quicker pathogen transmission within concentrated populations. Norovirus treatment aids in mitigating the effects of infectious disease by efficiently managing symptoms and curtailing its dissemination via appropriate hydration, hygiene, and isolation protocols. As an illustration, the World Health Organization, a Switzerland-based intergovernmental body, reported in March 2025 that approximately 10.8 million people worldwide, consisting of 6.0 million men, 3.6 million women, and 1.3 million children, were afflicted with tuberculosis in 2023. Consequently, the rising occurrence of infectious disease is stimulating the expansion of the norovirus treatment market.

How Is The Norovirus Treatment Market Divided Into Its Major Segments?

The norovirus treatment market covered in this report is segmented –

1) By Treatment: Electrolytes, Intravenous Fluids, Antipyretics, Analgesics, Anti-Diarrheal, Other Treatments

2) By Diagnosis: Bacteria Culture Test, Stool Tests, Other Diagnosis

3) By Route Of Administration: Oral, Intravenous

4) By End User: Hospitals, Clinics, Homecare Settings

Subsegments:

1) By Electrolytes: Oral Rehydration Salts (ORS), Sports Drinks, Pediatric Electrolyte Solutions

2) By Intravenous Fluids: Crystalloids, Colloids, Lactated Ringer’s Solution

3) By Antipyretics: Acetaminophen (Paracetamol), Ibuprofen, Aspirin

4) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen-Based Analgesics

5) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Diphenoxylate-Atropine

6) By Other Treatments: Antiemetics, Probiotics, Zinc Supplements

How Are Trends Transforming The Norovirus Treatment Market Landscape?

Major companies operating in the norovirus treatment market are prioritizing the development of innovative solutions, such as advanced mRNA vaccines. Their aim is to accelerate the creation of targeted immunization, improve protection against severe infections, and mitigate the global burden of norovirus-related illnesses. Advanced mRNA vaccines are recognized as next-generation immunizations that employ specially engineered messenger RNA to direct cells in producing specific proteins, thereby initiating a targeted immune response with better stability, efficacy, and adaptability against various infectious diseases. For instance, in October 2024, Moderna Inc., a US-based biotechnology company, partnered with the UK Health Security Agency (UKHSA), a UK-based government agency, to commence the world’s first Phase 3 trial of an mRNA norovirus vaccine (mRNA-1403) in the UK. This trial introduces a vaccine engineered to target the highly contagious norovirus by instructing the body to produce viral proteins that stimulate a robust immune response without utilizing the live virus. Noteworthy features of this launch include its reliance on stabilized mRNA for enhanced durability, its potential for rapid development in response to evolving strains, and its ability to elicit both antibody and T-cell responses.

Who Are The Prominent Organizations Shaping The Norovirus Treatment Market?

Major companies operating in the norovirus treatment market are Abbott Laboratories, Reckitt Benckiser Group plc, Nestlé Health Science, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Limited, Mylan (Viatris Inc.), Perrigo Company plc, Haleon plc, Church & Dwight Co. Inc., GlaxoSmithKline Consumer Healthcare, Sanofi Consumer Healthcare, Pfizer Consumer Healthcare, Ferring Pharmaceuticals, Fresenius Kabi AG, Baxter International Inc., B. Braun Melsungen AG, Hikma Pharmaceuticals PLC, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Pfizer Healthcare India Pvt. Ltd., Mead Johnson Nutrition (Reckitt), Danone Nutricia, Amneal Pharmaceuticals Inc., Ajanta Pharma Ltd.

Read the full norovirus treatment market report here:

https://www.thebusinessresearchcompany.com/report/norovirus-treatment-global-market-report

What Are The Top-Performing Regions Within The Norovirus Treatment Market?

North America was the largest region in the norovirus treatment market in 2025. The regions covered in the norovirus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Norovirus Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24629&type=smp

Browse Through More Reports Similar to the Global Norovirus Treatment Market 2026, By The Business Research Company

Nuclear Imaging Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-imaging-devices-and-equipment-global-market-report

Nuclear Medicine Radioisotopes Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-radioisotopes-global-market-report

Nuclear Medicine Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795